English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

oncgnostics Grants Exclusive License for GynTect to Sinopharm Subsidiary

Apr. 5, 2017

The Chinese pharma company Changchun Jienuo Medical Technology (CJMT), a subsidiary of the Chinese state-owned Sinopharm Group, has obtained an exclusive license from the German company oncgnostics for marketing GynTect® in China, Hongkong and Macao. Under the contract, oncgnostics will be entitled to undisclosed upfront, milestone and royalty payments.